BLOG

Video series: Understanding the science behind Biodesix’s work

Why interrogate the proteome? Doesn't genomic testing offer all the information we need? Why choose a technology platform like MALDI to interpret biological data from blood samples? We've developed a video series to answer your most-frequently asked questions about...

SUBSCRIBE TO THE BLOG

 


SUBSCRIBE TO THE BLOG

 


A Pre-Treatment Mass Spectrometry-Based Serum Proteomic Test is Able to Stratify Patients with Ovarian Cancer Receiving Adjuvant Chemotherapy According to Overall and Disease-Free Survival and Identify Patients Likely to Exhibit Chemo-Resistance

Authors Sabine Kasimir-Bauer, Dep. of Gynecol & Obstet., University of Essen, Essen, Germany Thomas Krivak, Allegheny Health Network, Pittsburgh, PA, USA Thomas Herzog, University of Cincinnati, Cincinnati, OH, USA Arni Steingrimsson, Biodesix, Inc.,...

Why proteomics?

We recognize that most people are already familiar with the promise of genomic testing. Proteomic testing, however, is less well understood. Take a look at our latest video on proteomics to learn more.

Patient Video: Victoria’s Story

Video: Victoria, stage 4 lung cancer patient, discusses the impact that liquid biopsy testing had on her treatment and outlook.

VIEW OUR BLOGS

ORDER A TEST KIT